Such is the suggestion of George Dvorsky in a recent blog post:
It seems obvious to me that a significant portion of the demand (and resultant shortage) of Adderall has to do with all those people who are taking it not because they suffer from any condition, but because they’re taking advantage of its nootropic qualities; it’s increasingly being used off-label as a cognitive enhancer.
George finishes with the idea that:
“…the concept of neuroenhancement needs to be normalized in society.”
On that point, I couldn’t agree more.